Sagimet Biosciences Inc.
SGMT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$45,567 | -$27,876 | -$30,499 | -$24,442 |
| Dep. & Amort. | $0 | $0 | $130 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,288 | $4,990 | $1,880 | $1,904 |
| Change in WC | -$1,048 | -$978 | $4,214 | -$55 |
| Other Non-Cash | -$1,108 | $98 | -$215 | $883 |
| Operating Cash Flow | -$42,435 | -$23,766 | -$24,490 | -$21,710 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$108,087 | -$19,620 | -$41,446 | $0 |
| Inv. Sales/Matur. | $46,404 | $32,200 | $9,436 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$61,683 | $12,580 | -$32,010 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $105,750 | $89,679 | $12 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$931 | -$3,512 | -$85 | $9,739 |
| Financing Cash Flow | $104,819 | $86,167 | -$73 | $9,739 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $701 | $74,981 | -$56,573 | -$11,971 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $75,139 | $158 | $56,731 | $68,702 |
| End Cash | $75,840 | $75,139 | $158 | $56,731 |
| Free Cash Flow | -$42,435 | -$23,766 | -$24,490 | -$21,710 |